Records containing: Hepatomegaly
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-23Phase 2 Study of Ruxolitinib in Idiopathic Hypereosinophilic Syndrome and Primary Eosinophilic Disorders
-
CLINICAL_TRIALS study record update · 2025-07-23Randomized Comparative Clinical Study of the Dietary Supplement "Gepaktiv" (International Name: Phenomenon) in Comparison With Ursodeoxycholic Acid (UDCA) and Ademetionine in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) and Hepatomegaly
-
CLINICAL_TRIALS study record update · 2025-02-27A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for Patients With Previously Treated AL Amyloidosis
-
CLINICAL_TRIALS study record update · 2023-02-13Biomarker for Sly Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL
-
CLINICAL_TRIALS study record update · 2023-02-13Biomarker for Farber Disease - An International, Multicenter, Epidemiological Protocol
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-02-13Biomarker for Gaucher Disease an International, Multicenter, Epidemiological Protocol
-
CLINICAL_TRIALS study record update · 2019-05-15Phase 2 Study of Nivolumab in Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
-
CLINICAL_TRIALS study record update · 2018-09-11Prevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes Mellitus Attending Assiut University Children Hospital
-
CLINICAL_TRIALS study record update · 2012-11-21Pilot Study Of Long-Acting Octreotide (Octreotide LAR® Depot) In The Treatment Of Patients With Severe Polycystic Liver Disease
-
CLINICAL_TRIALS study record update · 2009-02-17Long-Acting Lanreotide as a Volume Reducing Treatment of Polycystic Livers
-
CLINICAL_TRIALS study record update · 2008-11-13Open-Label Extension of the LOCKCYST Trial, LOCKCYST: Long Acting Lnareotide as as Volume Reducing Treatment of Polycystic Livers